CME/CE Library

PFF Summit 2025 Enduring

Jointly provided by Partners for Advancing Clinical Education and the Pulmonary Fibrosis Foundation.

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., Insmed Incorportated and United Therapeutics.

  • This activity should take approximately 1.75 – 3.75 hours to complete, per video
  • For additional information about the accreditation of this activity, please visit https://partnersed.com
  • Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media

Target Audience

This activity is intended for physicians, physician assistants, respiratory therapists, pharmacists, nurse practitioners, and registered nurses engaged in the care of patients with pulmonary fibrosis. 

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Explain the pathophysiology of IPF based on the most current data 
  • Accurately diagnose IPF using a systematic approach 
  • Effectively implement key diagnostic procedures including HRCT scanning and surgical lung biopsy 
  • Discuss recent evidence for treatments in the management of IPF/ILD 
  • Recognize genetic components of IPF, and how to implement precision medicine in ILD 
  • Describe the role of lung transplantation in IPF, and the factors that affect candidacy and timing
  • Provide patient lifestyle management tools which improve functional status  
  • Develop a comprehensive approach to the management of IPF/ILD, that includes both pharmacologic and non-pharmacologic therapies
  • Provide accurate and appropriate care and counsel for patients and their families 

Enduring CME Sessions and Faculty

Community Pulmonologists & Nurses and Allied Health Professionals
Evidence to Practice: ILD Guidelines and Progressive Pulmonary Fibrosis
From Genes to the Future of Pulmonary Fibrosis
ICU Care of ILD and MDD
Nurse and Allied Health Network (NAHN) 101

Professional Accreditation

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from May 1, 2026 through May 1, 2027:

  1. Review the objectives and disclosures
  2. Study the educational content
  3. Complete the Post Test if requesting MOC
  4. Complete the activity evaluations

For Pharmacists: Upon successfully completing the online evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has been posted.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

The faculty disclosures will be made at the beginning of their presentation(s).

Course List  


Joint Accreditation Statement

images

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the Pulmonary Fibrosis Foundation (PFF).  Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 22.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the posttest and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through Partners Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Partners permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 22.0 contact hours. 

Pharmacy Continuing Education

Partners designates this continuing education activity for 1.75 contact hour(s) (0.175 CEUs) of the Accreditation Council for Pharmacy Education.

Types of Activity: Knowledge
Universal Activity Numbers:

  • JA4008073-9999-26-106-H01-P: PFF Summit 2025 Enduring - Community Pulmonologist/ NAHN 201  
  • JA4008073-9999-26-107-H01-P: PFF Summit 2025 Enduring - Evidence to Practice: ILD Guidelines and Progressive Pulmonary Fibrosis
  • JA4008073-9999-26-108-H01-P: PFF Summit 2025 Enduring - From Genes to the Future of Pulmonary Fibrosis
  • JA4008073-9999-26-109-H01-P: PFF Summit 2025 Enduring - ICU Care of ILD and MDD
  • JA4008073-9999-26-110-H01-P: PFF Summit 2025 Enduring - NAHN 101

Social Work Continuing Education

 

As a Jointly Accredited Organization, Partners for Advancing Clinical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.75 Clinical continuing education credits.

Disclosure of Unlabeled Use 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.